Pharmaceutical Technology

JULY 7, 2022

CRYOPDP’s global teams are acutely aware of the seismic shift in focusing on cell and gene therapy drug development, and we are dedicated to supporting this emerging wave of new cell and gene therapies,” says Rossi.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

Pharma Mirror

JULY 23, 2021

The initial phase of the expansion will see the installation of two 2,000-liter single-use bioreactors within new, purpose-built manufacturing suites and associated investments to support early-phase clinical development as well as late-stage and commercial tech transfers. It will also.

Manufacturing 130

Manufacturing Gene Therapy Clinical Development Gene 130

XTalks

MAY 30, 2024

From Pharmacy School to Pharmacovigilance Ashish’s journey into pharmacovigilance began during his pharmacy school days, where an internship first exposed him to the field. “That’s where I developed the curiosity and a desire to contribute to patient safety. “I I see pharmacovigilance in the center of everything.

Compliance 105

Compliance Clinical Development Pharmacy Development 105

Pharmaceutical Technology

MARCH 2, 2023

Povorcitinib is under clinical development by Incyte and currently in Phase III for Hidradenitis Suppurativa. The company distributes Jakafi through a network of specialty pharmacy providers and wholesalers.

Pharmacy 100

Pharmacy Clinical Trials Clinical Trials Drugs 100

Pharmaceutical Technology

FEBRUARY 24, 2023

The failure of Jyseleca is expected to shift the attention of the late-stage pipeline of established drug classes such as the JAK or the interleukin-23 (IL-23) inhibitors towards developing novel CD therapeutic targets.

Marketing 147

Marketing Development Pharmacy Drugs 147

Pharmaceutical Technology

MARCH 1, 2023

Orvacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase II for Relapsed Multiple Myeloma. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities.

Pharmacy 100

Pharmacy Production Development Clinical Trials 100

The Pharma Data

SEPTEMBER 29, 2021

Heerspink, Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University center Groningen, Netherlands, and Co-Chair of the study’s Executive Committee. “If

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 26, 2023

Dezapelisib is under clinical development by Incyte and currently in Phase I for Chronic Lymphocytic Leukemia (CLL). The company distributes Jakafi through a network of specialty pharmacy providers and wholesalers.

Pharmacy 100

Pharmacy Development Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 26, 2023

Dezapelisib is under clinical development by Incyte and currently in Phase I for Hairy Cell Leukemia. The company distributes Jakafi through a network of specialty pharmacy providers and wholesalers.

Pharmacy 100

Pharmacy Development Drugs Clinical Trials 100

Pharmaceutical Technology

JANUARY 2, 2023

Danicamtiv is under clinical development by Bristol-Myers Squibb and currently in the Phase I and Phase II in clinical pathway. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities.

Drugs 100

Drugs Development Production Pharmacy 100

Pharmaceutical Technology

JUNE 6, 2023

The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. PF-06835375 Overview PF-06835375 is under development for the treatment of seropositive systemic lupus erythematosus, primary immune thrombocytopenia (ITP) and rheumatoid arthritis.

Contract Manufacturing 100

Contract Manufacturing Manufacturing Production Pharmacy 100

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under clinical development by Pfizer and currently in Phase I for Relapsed Multiple Myeloma. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies.

Hormones 113

Hormones Contract Manufacturing Manufacturing Development 113

pharmaphorum

OCTOBER 7, 2021

Dr Jean-Meidi Alili is a senior pharmacist in charge of Medicines and Research at the French healthcare network for rare metabolic diseases (G2M), where he is notably involved in implementing a drugs observatory and two ‘one-stop-shops’ in research and pharmacy.

Genome 98

Genome Genomics Medicine Life Science 98

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under clinical development by Pfizer and currently in Phase I for Myelofibrosis. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies.

Hormones 100

Hormones Contract Manufacturing Manufacturing Development 100

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under clinical development by Pfizer and currently in Phase I for Relapsed Chronic Lymphocytic Leukemia (CLL). Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies.

Hormones 100

Hormones Contract Manufacturing Manufacturing Development 100

pharmaphorum

JANUARY 22, 2021

These data cover about 30% of US pharmacy claims and about 50% of US medical claims for these conditions. These changes, initially presumed to be temporary, may continue beyond the pandemic. Impact on patients. Physicians are also adjusting to the impact of COVID-19 on their patients, including patient anxiety and personal finances.

Pharmacy 105

Pharmacy Marketing Research Vaccination 105

pharmaphorum

DECEMBER 1, 2022

One approach the industry has been exploring is to utilise community retail pharmacies as a central location for people to learn about and participate in clinical trials. Thanks to decentralised trials and technology that collects data remotely, people from anywhere can participate.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

pharmaphorum

AUGUST 10, 2020

Roche leads the clinical development of Evrysdi as part of a collaboration with the SMA Foundation and PTC Therapeutics. Evrysdi will be available in the US within two weeks for direct delivery to patients’ homes through Accredo Health Group, an Express Scripts specialty pharmacy.

FDA Approval 59

FDA Approval Drugs Gene Therapy Protein 59

The Pharma Data

MARCH 27, 2021

Dr. Martin received his MD at the University of Medicine and Pharmacy Timisoara, Romania. He completed his postdoctoral training at the University of Alabama at Birmingham in the Division of Developmental and Clinical Immunology. His expertise contributed to the discovery of medicines and the identification of external partnerships.

Research 52

Research Clinical Development Medicine Pharmacy 52

XTalks

APRIL 24, 2023

For rare disease studies where there is little or no clinical trial experience, outcome assessments would have to be validated within a clinical development program. This is important since not all pharmacies and sites are eligible to prepare and administer gene therapy due to biosafety and technical reasons.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

XTalks

NOVEMBER 28, 2023

Ilsun Hong VP and Product Evaluation Team Leader, Samsung Bioepis To have a biologic product ready for launch, it takes years of commitment from planning, early-stage development, clinical development, regulatory approval to supply readiness.

Production 98

Production Marketing Development Pharmacy 98

pharmaphorum

MARCH 8, 2022

Four years ago, I pivoted in my career, becoming a mechanical design engineer for a Manchester-based Heating, Ventilation and Air Conditioning (HVAC) company – designing air handling units for hospitals, pharmacies, schools and supermarkets. In October 2021, I joined the engineering department at Envair Technology, designing isolators.

Life Science 98

Life Science Engineer Scientist Doctor 98

XTalks

NOVEMBER 9, 2023

XTALKS WEBINAR: The Evolution of the Cardiovascular Clinical Development Landscape and Potential Role of GLP-1 RAs Live and On-Demand: Wednesday, December 6, 2023, at 11am EST (4pm GMT/UK) Register for this free webinar to learn about successful study outcomes in developing GLP1s to new therapeutic areas within cardiovascular medicine and more.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

The Pharma Data

DECEMBER 3, 2020

In this newly created role, Hain will work with GoHealth’s growing TeleCare team, directly building clinical functions. BioAge – Paul Rubin was named CMO of BioAge and will lead the company’s clinical development efforts. Prior to GoHealth, Hain served as CMO for Blue Cross and Blue Shield of Texas.

Development 52

Development Business Development Manufacturing Clinical Development 52

The Pharma Data

NOVEMBER 11, 2020

McChesney developed an early reputation for academic excellence, earning an undergraduate scholarship from the Ford Motor Company Fund, and a National Science Foundation fellowship for his postgraduate study.

Research 52

Research Development Pharmacy Medicine 52

The Pharma Data

APRIL 15, 2022

Not only is the new therapy stable in high heat, which could further streamline manufacturing and decrease the cost of goods for clinical development, it also holds promise for being self-administered as a one-time nasal spray, bypassing the need for medical professionals.

Antibody 52

Antibody Protein Engineer Research 52

The Pharma Data

JANUARY 24, 2021

Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval.

Drugs 52

Drugs Containment Development Clinical Development 52

The Pharma Data

JANUARY 13, 2021

.” MindMed Chief Development Officer Rob Barrow said, “Psychedelic therapies offer a once in a lifetime opportunity to revolutionize the delivery of mental healthcare.

Clinical Trials 52

Clinical Trials Clinical Trials Development Trials 52

The Pharma Data

DECEMBER 27, 2020

The US Department of Justice announced in October that opioid maker Purdue Pharma would plead guilty to fueling the nation’s opioid crisis in a $8 billion settlement, and sued Walmart recently for unlawfully dispensing controlled substances through its pharmacies, certifying the gravity of the opioid crisis. About TLC599.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40

The Pharma Data

OCTOBER 30, 2020

These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron’s business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron’s and its collaborators’ ability to continue (..)

Production 52

Production Antibody Manufacturing Trials 52

The Pharma Data

DECEMBER 17, 2020

Senior Vice President and Head of Global Clinical Development at Regeneron and lead author of the publication. patients under an Emergency Use Authorization, and we also continue a robust clinical development program.” “The investigational cocktail is now available to indicated high-risk U.S.

Antibody 52

Antibody Medicine Production Trials 52

The Pharma Data

NOVEMBER 20, 2020

the market potential for Zokinvy as a treatment for Progeria and PL; our progression and enrollment of our Phase 3 D-LIVR study in HDV; our ability to maintain supply of our commercial and clinical trial materials; our plans to advance Lambda in HDV in the U.S.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 5, 2020

REGN5458 and odronextamab are currently under clinical development, and their safety and efficacy have not been evaluated by any regulatory authority. Additionally, Regeneron bispecifics are manufactured using similar approaches used for human monoclonal antibody medicines, yielding similar properties and pharmacokinetics.

Antibody 40

Antibody Production Trials Medicine 40

The Pharma Data

OCTOBER 28, 2020

Senior Vice President and Head of Global Clinical Development at Regeneron. . “We will submit detailed results from this trial for publication in order to share insights with the public health and medical communities,” said David Weinreich, M.D.,

Antibody 40

Antibody Trials Production Clinical Trials 40

The Pharma Data

DECEMBER 29, 2020

Senior Vice President and Head of Global Clinical Development at Regeneron. . “We appreciate the continued support of patients and investigators around the world who are working to advance Regeneron’s antibody cocktail trials under very challenging circumstances,” said David Weinreich , M.D.,

Antibody 52

Antibody Trials Production Clinical Trials 52

The Pharma Data

NOVEMBER 5, 2020

Key Pipeline Progress Regeneron has more than 20 product candidates in clinical development, including five marketed products for which it is investigating additional indications. Updates from the clinical pipeline include: Dupixent ® (dupilumab). Non-GAAP net income per share – diluted (1). $. Business Highlights.

Sales 40

Sales Production Manufacturing Antibody 40

XTalks

MARCH 5, 2025

He is well known for his drug hunting capabilities and deep knowledge of drug discovery, early clinical development and strategic planning teams that have helped advanced multiple candidates into clinical trials for refractory cancers, autoimmune diseases, idiopathic pulmonary fibrosis (IPF), diabetic nephropathy, COPD and pain.

Life Science 64

Life Science Clinical Development Development Pharmacy 64